News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

May 15, 2024

Press Release: ECOG-ACRIN announces the recipients of its 2024 scientific leadership and mentorship awards

May 14, 2024

ECOG-ACRIN research at ASCO 2024

May 14, 2024

Coming soon: EA7222 for patients with advanced soft tissue sarcoma

May 14, 2024

myeloMATCH, the next revolution in the NCI’s National Clinical Trials Network

May 14, 2024

Increasing inclusion and equity for Black women in breast cancer clinical trials (mentions EAZ171)

May 14, 2024

NCCN recommends universal testing for MSI and dMMR for all newly diagnosed gastric cancer patients

May 9, 2024

TMIST breast cancer screening trial update

May 8, 2024

Press Release: ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform

May 1, 2024

The May News from ECOG-ACRIN blog is now available

April 24, 2024

Press Release: ECOG-ACRIN research at ASCO 2024

April 15, 2024

Boston Gene announces participation in ComboMATCH

April 9, 2024

The April 2024 News from ECOG-ACRIN blog is now available

April 4, 2024

The Spring 2024 advocacy blog Considering Clinical Trials is now available

April 3, 2024

Press Release: ECOG-ACRIN Breast Cancer Committee chair Antonio Wolff tapped to co-lead the NCI Breast Cancer Steering Committee

March 20, 2024

Press Release: ARPA-H appoints Etta Pisano to lead its Advancing Clinical Trials Readiness Initiative

March 7, 2024

The March News from ECOG-ACRIN blog is now available

March 4, 2024

Press Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

March 1, 2024

Attention radiation oncologists and trainees: Travel funds are available for the Spring 2024 Group Meeting (apply now)

February 28, 2024

Attention CRAs: Travel funds are available for the Spring 2024 Group Meeting (apply now)

February 16, 2024

AACR’s Clinical Cancer Research publishes a review article, “Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial”

 
ECOG-ACRIN Cancer Research Group